Stay updated on FTX-6058 Safety and PK in Healthy Volunteers Clinical Trial
Sign up to get notified when there's something new on the FTX-6058 Safety and PK in Healthy Volunteers Clinical Trial page.

Latest updates to the FTX-6058 Safety and PK in Healthy Volunteers Clinical Trial page
- Check6 days agoChange DetectedThe record presents details of the completed Phase 1 FTX-6058 study in healthy adults and adults with sickle cell disease, including its design, eligibility criteria, outcomes, and locations.SummaryDifference62%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, replacing the expected content with a standard error view and header/footer. This indicates that access to the study record is blocked.SummaryDifference0.5%

Stay in the know with updates to FTX-6058 Safety and PK in Healthy Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FTX-6058 Safety and PK in Healthy Volunteers Clinical Trial page.